Form 4: Sigmatron International CFO Acquires Stock Options

Sentiment:

SEC Form 4 Filing


Sigmatron International's Chief Financial Officer, Frank Cesario, acquired 30,000 stock options on November 11, 2024, at an exercise price of $2.93 per share.

Summary

  • Frank Cesario, the Chief Financial Officer of Sigmatron International Inc., acquired a total of 30,000 stock options on November 11, 2024.
  • These options are divided into four tranches of 7,500 each, with different exercisable dates starting from November 11, 2025, and expiring on November 11, 2034.
  • The exercise price for all options is $2.93 per share.
  • The options were granted under a single stock option plan and stock option agreement.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

  • The acquisition of stock options by the CFO could indicate confidence in the company's future performance.
  • The staggered vesting schedule of the options may incentivize long-term commitment from the CFO.

Risks

  • The exercise of these options could potentially dilute existing shareholders' equity if a large number of options are exercised at once.

Industry Context

Stock option grants are a common practice in corporate compensation, particularly for executives, to align their interests with those of shareholders and incentivize performance.

Comparison to Industry Standards

  • Stock option grants are a standard form of compensation for executives in publicly traded companies.
  • The vesting schedule and exercise price are typical for such grants, although specific terms can vary widely based on company performance and individual agreements.
  • Companies like Jabil and Flex also use stock options as part of their executive compensation packages.

Stakeholder Impact

  • The stock option grant could positively impact shareholder value if the CFO's performance leads to increased company profitability.
  • The grant may also incentivize the CFO to make decisions that benefit the company's long-term growth.

Key Dates

DateDescription
11/11/2024Date of stock option acquisition.
11/11/2025First tranche of options becomes exercisable.
11/11/2026Second tranche of options becomes exercisable.
11/11/2027Third tranche of options becomes exercisable.
11/11/2034Expiration date for all stock options.
11/15/2024Date of filing of the Form 4.

Keywords

stock options, insider trading, executive compensation, form 4, sigmatron international, SGMA, CFO, Frank Cesario

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.